MaxCyte Receives Nasdaq Delisting Notice for Sub-$1.00 Bid Price

summarizeSummary

MaxCyte, Inc. received a notice from Nasdaq regarding non-compliance with the minimum $1.00 bid price requirement, initiating a 180-day compliance period to avoid potential delisting.

check_boxKey Events

• Nasdaq Non-Compliance Notice

  MaxCyte received a notice from Nasdaq on March 16, 2026, for failing to maintain a minimum bid price of $1.00 for 30 consecutive trading days, violating Nasdaq Listing Rule 5450(a)(1).

• 180-Day Compliance Period

  The company has an initial compliance period of 180 calendar days, until September 14, 2026, to regain compliance. This requires the closing bid price to meet or exceed $1.00 for a minimum of 10 consecutive trading days.

• Potential Delisting Risk

  Failure to regain compliance within the initial period could lead to eligibility for an additional 180-day period if the company transfers to the Nasdaq Capital Market, or ultimately, delisting from Nasdaq.

auto_awesomeAnalysis

This 8-K filing signals a significant risk to MaxCyte's continued listing on the Nasdaq Global Select Market. The company's stock has traded below $1.00 for 30 consecutive days, triggering a formal notice from Nasdaq. While there is an initial 180-day period to regain compliance, failure to do so could lead to a transfer to the Nasdaq Capital Market or, ultimately, delisting. Delisting can severely impact a company's liquidity, investor confidence, and ability to raise capital. Investors should monitor the company's stock performance closely and any strategic actions taken to address this deficiency, such as a potential reverse stock split.